NewTradingView.com – Investing and Stock News
Investing and Stock News
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
Investing

Coinbase stock opened 30% up on Thursday: explained here

by August 4, 2022
written by August 4, 2022

Coinbase Global Inc (NASDAQ: COIN) stock opened 30% up on Thursday after BlackRock announced a partnership with the crypto exchange that will offer its institutional investors access to Bitcoin.

Brief overview of the announced partnership

The asset manager was “studying” crypto and related technologies in recent months to better serve its customers that have been getting interested in crypto.

The partnership with Coinbase, will secure access for its institutional investors to crypto trading, custody, prime brokerage, and reporting capabilities. In a written statement, Joseph Chalom – Global Head of Strategic Ecosystem Partnerships at BlackRock said:

Our institutional clients are increasingly interested in gaining exposure to digital assets. The partnership will let them manage their Bitcoin exposure directly in their existing portfolio management and trading workflows.

Coinbase to report Q2 results next week

Coinbase Global is expected to report its results for the fiscal second quarter on August 9th. Consensus is for it to lose $3.04 a share (down 147% YoY) on $877.32 million in revenue (down 60% YoY).

Heading into the earnings print, Wall Street has a consensus “overweight” rating on Coinbase stock that’s down more than 50% for the year, even though it has roughly doubled in about a week as Bitcoin and Ethereum continue to bounce off their lows.

The rally might also be related to a short squeeze. “COIN” is the most mentioned stock on WallStreetBets (Reddit) this morning. In June, Coinbase said it’s cutting its workforce by 18% to minimise costs amidst a looming recession.

The post Coinbase stock opened 30% up on Thursday: explained here appeared first on Invezz.

0 comment
0
FacebookTwitterPinterestEmail

previous post
Price Stability and the Fed
next post
Eli Lilly Q2 results: its Alzheimer’s drug could be ‘the biggest drug in history’

You may also like

UBS renames Sergio Ermotti as CEO to lead...

March 29, 2023

Nextracker stock could climb to $40: Bank of...

March 29, 2023

Next plc results: full-year sales up 8.4%

March 29, 2023

CAC 40 forecast amid the recent French protests

March 29, 2023

If you started investing at the stock market...

March 29, 2023

Nikkei 225 price prediction as Japanese parliament votes...

March 29, 2023

Next PLC share price dives after weak guidance:...

March 29, 2023

Affirm stock price forecast: AFRM braces for more...

March 29, 2023

Adani Enterprises share price analysis points to a...

March 29, 2023

Needham analyst reacts to Micron Q2 earnings

March 29, 2023
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Popular Posts

  • 1

    Headline Inflation Falls, But Core Inflation Remains Elevated

  • 2

    My Trigger to Enter $VAPR

  • 3

    Multi-Millionaire Trader Explains Why You Should Start Trading With A Small Account {VIDEO}

  • 4

    Pay Attention to These Stocks

  • 5

    Scaling Up Tips From A 24-Year Old Millionaire Trader {VIDEO}

Recent Posts

  • UBS renames Sergio Ermotti as CEO to lead Credit Suisse merger

    March 29, 2023
  • Nextracker stock could climb to $40: Bank of America

    March 29, 2023
  • Soracom Adds Industrial SIM to IoT SIM and eSIM Portfolio

    March 29, 2023
  • Global Cellular IoT Module Shipments Jump 14% YoY in 2022 to Reach Highest Ever

    March 29, 2023
  • Next plc results: full-year sales up 8.4%

    March 29, 2023

Categories

  • Economy (715)
  • Editor's Pick (309)
  • Investing (2,019)
  • Stock (9)
  • About Us
  • Email Whitelisting
  • Terms and Conditions
  • Privacy Policy
  • Contacts

Disclaimer: NewTradingView.com, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


Copyright © 2023 NewTradingView.com All Rights Reserved.


Back To Top
NewTradingView.com – Investing and Stock News
  • Investing
  • Stock
  • Economy
  • Editor’s Pick